1 – 6 of 6
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 1995
-
Mark
Urinary excretion of melanocyte metabolites during treatment with chloroquine phosphate
(
- Contribution to journal › Article
- 1993
-
Mark
Monitoring CA 125 serum levels during early chemotherapy is an excellent prognostic method in advanced ovarian cancer
(
- Contribution to journal › Article
- 1992
-
Mark
Long-term follow-up of ovarian cancer with monthly determinations of serum CA 125
(
- Contribution to journal › Article
-
Mark
The stability of 5-S-cysteinyldopa and 6-hydroxy-5-methoxyindole-2-carboxylic acid in human urine
(
- Contribution to journal › Article
- 1990
-
Mark
Serum half-life of the tumor marker CA 125 during induction chemotherapy as a prognostic indicator for survival in ovarian carcinoma
(
- Contribution to journal › Article
- 1987
-
Mark
Determination of 5-S-cysteinyldopa in human urine by direct injection in coupled-column high-performance liquid chromatography
(
- Contribution to journal › Article